Allspring Global Investments Holdings, LLC Eliem Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$2.77 - $8.4 $6,648 - $20,160	-2,400 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$8.01 - $13.15 $3,844 - $6,312	-480 Reduced 16.67%	2,400 $20,000
Q4 2021 Jan 28, 2022	BUY	$8.61 - $20.47 $24,796 - $58,953	2,880 New	2,880 $30,000

Others Institutions Holding ELYM

# of Institutions

Shares Held

53.1M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

31.4M
Shares

$129 Million
2.23% of portfolio
Janus Henderson Group PLC London, X0

3.61M
Shares

$14.8 Million
0.01% of portfolio
Samsara Bio Capital, LLC Palo Alto, CA

2.61M
Shares

$10.7 Million
7.7% of portfolio
Boxer Capital, LLC San Diego, CA

2.6M
Shares

$10.7 Million
0.7% of portfolio
Deep Track Capital, LP Greenwich, CT

2.17M
Shares

$8.92 Million
0.41% of portfolio

View Full List

About Eliem Therapeutics, Inc.

Ticker ELYM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,567,700
Market Cap $109M
Description
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...

More about ELYM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account